Maged Goubran1, Audrey Peiwan Fan1, Praveen Gulaka1, David Douglas1, Steven Chao2, Andrew 5 Graduates of Quon1, Greg Zaharchuk1, Minal Vasanawala1, and Michael Zeineh1
1Department of Radiology, Stanford University, Stanford, CA, United States, 2Department of Neurology, Stanford University, Stanford, CA, United States
Synopsis
Hippocampal subfields are selectively affected in AD, however the
hippocampus is assessed as a whole in PET studies. In this work we investigate
the metabolic, perfusion and diffusion changes within the subfields of patients
with MCI and AD using a simultaneous PET-MR scanner. Our preliminary results
demonstrate significant reduction in metabolism and perfusion that are
appreciated on the subfield level but not when assessing the hippocampus as a
whole. This work suggests that subfield assessment is potentially more
sensitive to pathological changes in AD than whole hippocampus analysis, and
highlights the utility of simultaneous PET-MR as a tool for discovering novel
biomarkers in neurodegenerative diseases. Target audience
Scientists/MR physicists/Neurologist/Radiologists/Nuclear Medicine
Physicians with interest in Alzheimer’s disease, dementia and PET-MR studies
Purpose
Study the metabolic changes using 18F-FDG-PET, perfusion using arterial
spin labeling (ASL) and white matter integrity using diffusion tensor imaging
(DTI) in the hippocampal subfields of patients suffering from mild cognitive
impairment (MCI) and Alzheimer’s disease (AD).
Methods
Cohort &
Image acquisition
12 subjects with
memory complaints were recruited
as part of an ongoing study, in accordance with IRB and HIPAA.
Stratification was based on clinical dementia rating (CDR) scores. 4 subjects
had probable AD (CDR=2, 68±4 yr), 4 subjects had MCI (CDR=1, 65±5 yr) and 4
subjects did not have any clinical evidence of MCI/AD and were considered controls
(CDR=0, 70±6 yr). Patients underwent a 75-minute FDG PET-MRI scan on a
simultaneous time-of-flight 3T PET-MR scanner (SIGNA, GE , Waukesha, WI, USA)
following a 5 mCi intravenous injection of 18F-FDG. The MRI sequences are
described in Table 1.
Image processing
Pixel-wise
quantitative cerebral glucose uptake maps (CMRGlu) were computed based on
pharmacokinetic modeling of the dynamic PET acquisition
to minimize errors encountered in semi-quantitative standardized uptake
value reconstruction. The carotid artery was delineated on a 10-second PET image during the
initial tracer uptake and used to compute an arterial input function
(AIF) (Figure 1). Kinetic modeling was performed using a
two-compartment model in Pmod [1]. Cerebral blood flow (CBF) was computed from
the pseudo-continuous ASL.
High-resolution diffusion tensor imaging (DTI) was eddy and
distortion corrected using FSL 5.0. Our whole-brain T1 IR-SPGR
and FLAIR were input into a Freesurfer pipeline to parcellate
the brain and compute intracranial volume (ICV).
Subfield
segmentation
Hippocampal
subfields were segmented using 3D T1-weighted IR-SPGR and high-resolution oblique coronal
thin-section T2-weighted images with ASHS [2], which
automatically segments the following subfields: cornu ammonis (CA) 1, CA2, CA3,
dentate gyrus (DG)+CA4, subiculum (SUB) and entorhinal cortex (ERC) (Figure
2). CA2+CA3 were combined into a single subfield because of their small
size. The whole hippocampus was all of these subfields combined.
Statistical
analysis
An ANOVA was
performed between the three groups (Controls, MCI and AD) separately for
volumetry (adjusting for ICV), CMRGlu (adjusting for cerebellar metabolism), CBF
(adjusting for cerebellar perfusion), fractional anisotropy (FA), and mean
diffusivity (MD) within each subfield.
Post hoc Tukey’s test was subsequently performed when the F-test was
significant. Statistical analysis was performed in Matlab and Stata.
Results
Whole
hippocampus: The analysis did not yield significant results in the one-way ANOVA
between the groups for volumes, CMRGlu, CBF, FA, or MD.
Hippocampal
subfields: The subiculum was the only subfield to show a significant volume
decrease (p=0.037, F=5.46). CMRGlu was reduced significantly in AD and
MCI patients with the highest effect for metabolic change seen in DG+CA4 (p=0.0158,
F=6.81) (Figure 3). Post hoc Tukey’s test showed that CMRGlu
in the AD group was significantly lower than controls in the DG+CA4 subfield
(no significance was found between controls and MCI). A significant decrease in
CBF across the three groups was also found in the subiculum (p=0.043, F=4.93)
(Figure 4). No significant differences were found in the analysis
of FA and MD.
Discussion
Histological data
suggests that the hippocampal subfields are selectively affected in AD [3].
However, hippocampal subfield structures have not been explored with PET
largely due to poor spatial resolution and the complexity of spatial alignment
of small structures [4]. The simultaneous imaging nature of integrated PET-MR
scanners decreases the registration complexity and facilitates a multimodal
analysis. While the hippocampal subfields are at the limit of PET spatial
resolution, we demonstrate the utility of subfield analysis: in this small
cohort, a significant decline in CMRGlu was only detected with the subfield
analysis. The association of volume and perfusion changes and dissociation of
both with glucose metabolism suggests separable processes may accompany the
neurodegeneration. The glucose metabolic changes may be secondary to reduced
entorhinal perforant input into the hilus, whereas the subicular decreases may
be a downstream effect.
Conclusion
Our preliminary
results demonstrate that metabolic and perfusion changes can be simultaneously
assessed at the subfield level and
that subfield
analysis may be more sensitive to these pathological changes than global
hippocampal assessment. This study highlights the utility of simultaneous
MR-PET as a tool for discovering novel biomarkers for early diagnosis of AD and
disentangling microstructural and metabolic derangements accompanying neurodegeneration.
Future work will include a larger patient cohort and assessment of
resting-state connectivity.
Acknowledgements
We would like to thank Dawn Holley and Pragya Tripathi for their help and support. This study was funded by GE Healthcare. References
[1] Zanotti-Fregonara
et al., J Cereb Blood Flow Metab 2011; 31:1986:1998
[2] Yushkevich et
al., Human Brian Mapping 2014; 36:258-287
[3] West et al.,
Neurobiol Aging 2004; 25:1205-1212
[4] Mosconi et
al., Neurology 2005;64:1860-1867